Warning letter
Apira Science, Inc.: warning letter of Apr 17, 2012
FDA warning letter 233517 · Los Angeles District Office
Key facts
| Reference number | 233517 |
|---|---|
| Company | Apira Science, Inc. |
| Subject | Premarket Approval/Adulterated |
| Issue date | Apr 17, 2012 |
| Posted date | Apr 17, 2012 |
| Issuing office | Los Angeles District Office |
| Product type | Devices |
| CFR sections cited | 820.40, 820, 807.81(b) |
| Inspection city | Albuquerque |
| Inspection ZIP | 87107 |
| Inspection start date | Aug 16, 2011 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: